Renal Cell Cancer Clinical Trials

76 clinical trials for Renal Cell Cancer across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers — RECRUITING · PHASE1
• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy — RECRUITING · PHASE1
• Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy — RECRUITING
• Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma — RECRUITING
• Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma — RECRUITING · PHASE4
• Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer — RECRUITING · PHASE1
• Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. — RECRUITING · PHASE4
• Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study — RECRUITING · NA
• The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study — RECRUITING
• TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors — RECRUITING · PHASE1
• Optimising Renal Tumour Management Through Artificial Intelligence Modules — RECRUITING
• Prehabilitation Prior to Surgery for Kidney Tumors — RECRUITING · NA
• A Study of IBI363 in Subjects with Advanced Solid Malignancies — RECRUITING · PHASE2
• Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome — RECRUITING
• Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA — RECRUITING
• Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer — COMPLETED
• Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC — NOT_YET_RECRUITING · PHASE2
• Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) — COMPLETED · PHASE3
• Percutaneous Tumor Ablation Vs Partial Nephrectomy for Small Renal Mass: the Impact of Histologic Variant and Tumor Size — COMPLETED
• Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma — NOT_YET_RECRUITING
• A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. — COMPLETED
• Study of PF-07263689 in Participants With Selected Advanced Solid Tumors — TERMINATED · PHASE1
• DNX-2440 for Resectable Colorectal Liver Metastasis — SUSPENDED · PHASE1
• CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers — COMPLETED · PHASE1
• Fear of Cancer Recurrence in Genitourinary Cancer — COMPLETED
• WIRE - Novel Treatments in Renal Cell Cancer — OTHER · PHASE2
• Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib — WITHDRAWN · PHASE2
• ImmuniCell® in Patients With Advanced Cancers — TERMINATED · PHASE2
• A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) — COMPLETED · PHASE1
• Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers — COMPLETED · PHASE1
• Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer — COMPLETED · PHASE1
• Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma — TERMINATED · PHASE1
• Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma — OTHER · PHASE2
• Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients — TERMINATED
• Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention — COMPLETED · NA
• Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma — WITHDRAWN · PHASE1
• A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031) — TERMINATED · PHASE1
• NANOTECH RCC Biomarkers — COMPLETED
• Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors — COMPLETED · NA
• Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer — COMPLETED · PHASE1
• Study of Muscle Energy Metabolism in RCC Patients Treated With Sunitinib — WITHDRAWN
• Urine Proteome of Surgical Patients and Healthy Volunteers — COMPLETED
• Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) — TERMINATED · PHASE1
• A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer — COMPLETED · PHASE2
• Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST — COMPLETED
• An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma — COMPLETED
• Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides — OTHER · PHASE1
• Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer — COMPLETED · PHASE2

Refine this search